Home›Stock Screener›Sanjivani Paranteral

Sanjivani Paranteral Share Price Today | Stock Price & Sanjivani Paranteral Share Screener

SANJIVIN Pharmaceuticals
Live Share Price BSE
₹165.95
▲ 0.85 (0.51%)
2026-10-05 00:00:00

As of October 5, 2026, the live Sanjivani Paranteral share price (BSE: SANJIVIN) is ₹165.95, up 0.51% from the previous close, with shares trading between ₹165.35 and ₹172.95 in today's trading session, and a 52-week range of ₹129.30–₹239.65. Check SANJIVIN 52-week performance for the annual price range and momentum. Use the Sanjivani Paranteral stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sanjivani Paranteral opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹24 and net income of ₹3, with EBITDA of ₹4, an operating margin of 17.0% and a profit margin of 12.5%.

Sanjivani Paranteral Market Cap ₹211.77 Cr.
SANJIVIN P/E Ratio (TTM) 27.20
Sanjivani Paranteral P/B Ratio 4.20
EPS (TTM) ₹5.49
Dividend Yield -
Debt to Equity 0.26
SANJIVIN 52 Week High ₹239.65
Sanjivani Paranteral 52 Week Low ₹129.30
Operating Margin 17.00%
Profit Margin 12.50%
SANJIVIN Revenue (TTM) ₹24.00
EBITDA ₹4.00
Net Income ₹3.00
Total Assets ₹88.00
Total Equity ₹51.00

Sanjivani Paranteral Share Price Chart

Track the current stock price of Sanjivani Paranteral with an interactive chart. Analyse SANJIVIN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sanjivani Paranteral stock quote in one place.

The quote of ₹165.95 sits between the 52-week low of ₹129.30 and the 52-week high of ₹239.65, and the latest session moved 0.51% from the previous close.

Sanjivani Paranteral Company Profile - Fundamental Screener

Screen Sanjivani Paranteral company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANJIVIN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE860D01013.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE860D01013

Sanjivani Paranteral Balance Sheet Screener

Screen SANJIVIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹88, up from ₹78 in 2025.

Latest statistics put total assets at ₹88 and shareholder funds at ₹51, with a leverage ratio of 0.26.

Item 2026 2025 2024

Assets

Total Assets 88 78 43
Current Assets 36 34 29
Fixed Assets 47 21 10

Liabilities

Total Liabilities 0 0 0
Current Liabilities 11 7 2
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 51 40 28
Share Capital 12 12 12
Reserves & Surplus 36 25 14

Sanjivani Paranteral Income Statement Screener - Profit & Revenue Analysis

Screen Sanjivani Paranteral income statement and profit fundamentals. Analyze SANJIVIN quarterly results. Sanjivani Paranteral reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹24 and net profit was ₹3, equal to earnings per unit of ₹2.03, at an operating margin of 17%.

In that period expenses were ₹20, interest cost ₹0 and tax ₹1. The next period listed, 2026-Mar, shows revenue of ₹14 and net profit of ₹1.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec

Revenue and Expenses

Revenue 24 14 22 16 18 19 18 19 17 13 15
Expenses 20 12 18 13 15 16 15 15 14 11 13

Operating Costs and Margins

EBITDA 4 2 4 2 3 3 3 3 2 2 2
Operating Profit % 17.00% 12.00% 17.00% 15.00% 15.00% 14.00% 15.00% 16.00% 14.00% 17.00% 13.00%
Depreciation 1 1 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 3 1 4 2 2 3 3 3 2 2 2
Tax 1 1 1 1 1 1 1 1 1 1 0
Net Profit 3 1 3 2 2 2 2 2 2 1 2
EPS 2.03 0.49 2.21 1.33 1.46 1.84 1.62 1.96 1.47 1.08 1.65

Sanjivani Paranteral Cash Flow Screener - Liquidity Fundamentals

Screen SANJIVIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹0.

Over the same period, investing activities used ₹10 and financing activities provided ₹10.

Item 2026-March 2025-March 2024-March

Cash from Operations and Investing

Operating Activities 0 12 -11
Investing Activities -10 -22 -12

Financing and Net Cash

Financing Activities 10 11 23
Net Cash Flow 0 1 0

Sanjivani Paranteral Shareholding Pattern Screener

See Sanjivani Paranteral shareholding pattern with promoter, FII, and DII holdings. Check Sanjivani Paranteral promoter holding and ownership changes for SANJIVIN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 31.56%, foreign institutions 0.00%, domestic institutions 5.45% and the public 49.92%, spread across 5,880 shareholders.

The shareholder count was 5,880 in 2026-Jun, compared with 5,933 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 31.56% 31.26% 31.20% 31.20% 28.87% 28.87% 27.67% 27.67%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 5.45% 6.04% 6.04% 6.03% 6.15% 6.15% 6.25% 6.25%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 49.92% 50.05% 51.06% 50.99% 52.60% 52.43% 54.08% 53.90%
Other Holding 13.06% 12.66% 11.70% 11.78% 12.38% 12.54% 11.99% 12.18%
Shareholder Count 5,880 5,933 6,017 6,307 6,429 6,447 6,618 6,731

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sanjivani Paranteral. Sanjivani Paranteral dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.50 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.50 0.38%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Sanjivani Paranteral Stock Index Membership - Nifty & Sensex

See which indices include Sanjivani Paranteral stock. Check SANJIVIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Sanjivani Paranteral is not part of any tracked indices.
Only major market indices are tracked in our system.

Sanjivani Paranteral Market Events Screener - Corporate Actions

Get Sanjivani Paranteral corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sanjivani Paranteral stock events that may affect SANJIVIN share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 16, 2026, with a record date of September 16, 2026.

It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-16 2026-09-16 Annual General Meeting NA -8.32%
2026-08-14 2026-08-14 Quarterly Result Announcement NA -0.91%
2026-05-14 2026-05-14 Quarterly Result Announcement NA -5.69%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 24.37%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -3.28%
2025-09-26 2025-09-26 Annual General Meeting NA 10.60%
2025-09-19 2025-09-19 Dividend ₹ 0.50 /share 12.66%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 1.05%
2025-05-27 2025-05-27 Quarterly Result Announcement NA -1.67%
2025-02-10 2025-02-10 Quarterly Result Announcement NA -4.99%
2024-10-28 2024-10-28 Quarterly Result Announcement NA -5.46%
2024-09-24 2024-09-24 Annual General Meeting NA 23.26%
2024-01-18 2024-01-18 Extraordinary General Meeting NA 0.36%

Sanjivani Paranteral Competitors Screener - Peer Stocks Comparison

Screen SANJIVIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 427,010 35.84 61,674 12.69% 11,565 33.78
Divis Laboratories 244,125 84.36 11,067 13.95% 2,568 49.73
Torrent Pharmaceuticals 181,512 84.01 13,886 20.34% 2,138 41.48
Zydus Life Science 113,616 24.88 27,658 17.64% 5,026 46.18
Cipla 107,890 32.42 29,045 2.24% 3,870 32.87
Laurus Labs 106,517 98.56 6,868 22.01% 890 56.11
Mankind Pharma 102,394 50.48 14,636 14.85% 1,938 55.53
Dr Reddys Laboratories 100,412 31.47 35,059 3.90% 4,158 52.91
Aurobindo Pharma 96,370 25.97 34,145 5.56% 3,503 49.89
Lupin 91,961 16.71 29,039 26.75% 5,356 29.12

Sanjivani Paranteral Company Announcements - News & Reports Screener

Screen SANJIVIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 1, 2026.

The next most recent announcements are dated September 30, 2026 and September 23, 2026.

Date Update Actions
2026-10-01 Closure of Trading Window -
2026-09-30 Closure of Trading Window -
2026-09-23 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Clarification Regarding Objects Of The Issue -
2026-09-16 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-16 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-26 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-24 Record Date For AGM -
2026-08-24 Book Closure For AGM -
2026-08-24 Notice Of AGM For 2025-26 -
2026-08-24 Reg. 34 (1) Annual Report. -
2026-08-24 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-08-24 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-08-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-14 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-14 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-14 Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th August 2026 -
2026-08-14 Financials Results For The Quarter Ended 30Th June 2026 -
2026-08-10 Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday 14Th August 2026 Pursuant To Regulation 29(1)(A) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-07-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-23 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹165.95, within a 52-week range of ₹129.30 to ₹239.65. The P/E ratio is 27.20 and the P/B ratio is 4.20, with earnings per unit of ₹5.49. Market capitalisation stands at ₹211.77 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 7, 2026. This page covers 3 balance sheet periods, 11 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.